["Blind" trans-bronchial biopsy of the lung in the diagnosis of interstitial lung diseases].
The aim of the study was to assess the diagnostic effectiveness and safety of "blind" transbronchial lung biopsy (B-TBLB) in interstitial lung diseases (ILD). The diagnostic yield of B-TBLB performed in 44 patients was compared with similar yield of classical TBLB carried out in 25 patients. A diagnosis was made by B-TBLB in 29 patients (65.9%) and 14 (56%) by classical TBLB. Most often sarcoidosis, allergic alveolitis, pneumoconioses were found. Side effects were seen in both groups: in the B-TBLB group in 11.4%, in patients that underwent classical TBLB in 32%. It seems that blind transbronchial lung biopsy is a safe, effective and acceptable diagnostical method of interstitial lung disorders.
Pirozyński
M
M
Instytutu Gruźlicy i Chorób Płuc w Warszawie.
Szymańska
D
D
Targosz
L
L
Cieślicki
J
J
Meleniewska-Maciszewska
A
A
Załeska
J
J
D000328:Adult; D000368:Aged; D000542:Alveolitis, Extrinsic Allergic / Q000473:pathology*; D001706:Biopsy / Q000379:methods; D001980:Bronchi / Q000473:pathology; D003937:Diagnosis, Differential; D005188:False Negative Reactions; D006801:Humans; D008168:Lung / Q000473:pathology*; D008875:Middle Aged; D011009:Pneumoconiosis / Q000473:pathology*; D011658:Pulmonary Fibrosis / Q000473:pathology*; D012507:Sarcoidosis / Q000473:pathology*
"Slepa" transbronchialna biopsja płuca w diagnostyce śródmiazszowych chorób płuc.